The Attenuation Paradox in Bundibugyo Virus Disease: Case Fatality, Ascertainment, and Delayed Outbreak Recognition

Bundibugyo virus has caused three recognised outbreaks, and each was recognised late. The usual reading of that record treats the delay as a failure of investment, diagnostics or governance. This review sets out a partly mechanistic alternative: the low case fatality ratio observed early in a Bundibugyo virus outbreak is itself one of the conditions that produces the delay, and the delay in turn depresses the observed ratio further. The evidence is organised around three comparison tables: the burden, severity and recognition interval of each outbreak; the presenting clinical features set against a matched Ebola virus series; and the point at which species assignment failed in each event. A schematic draws the relationships together. Two findings emerge. The clinical syndrome does not discriminate between species: haemorrhage was documented in roughly a quarter of confirmed patients in both the 2007–08 Bundibugyo series and a 2014 Ebola virus series, so the presenting picture cannot carry the explanatory weight often placed on it. The discriminating failures are instead genomic and diagnostic, and the early case fatality ratio operates as a surveillance trigger that is biased downward precisely when ascertainment is narrowest. The 2026 epidemic, in which the confirmed ratio rose from 12.1% to 44.3% while the virus doubled every 5.5 days, fits this account better than it fits a change in virulence. A fatality ratio from the first weeks of a filovirus outbreak should therefore be read as an index of surveillance maturity rather than of danger, and escalation should be governed by species-inclusive confirmation.